Skip to main content
. 2025 Feb 24;263(7):2017–2024. doi: 10.1007/s00417-025-06776-y

Table 3.

The rates of improvement in mean BCVA for IE and UE in the low- and high-dose groups

Evaluation criteria Low dose group High dose group
IE UE IE UE
Gain of ≥ 3 ETDRS lines 4(66.7%) 0(0.0%) 2(33.3%) 3(50.0%)
Within 3 lines 2(33.3%) 6(100.0%) 4(66.7%) 3(50.0%)
Loss of ≥ 3 lines 0(0.0%) 0(0.0%) 0(0.0%) 0(0.0%)

Injected eye

Uninjected eye